Discovery to Product
Overview
Discovery to Product (D2P) is a university-based accelerator that provides funding, mentorship, and resources to commercialize innovations from the University of Wisconsin–Madison community.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Atrility Medical | Sep 2024 | Grant | Co-investor |
| Last Lock | Nov 2019 | Pre Seed | Co-investor |
| BrainXell Therapeutics | Nov 2016 | Grant | Lead |
| BrainXell | Nov 2016 | Accelerator | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Discovery to Product based?
Discovery to Product is headquartered in Madison, Wisconsin, United States.
When was Discovery to Product founded?
Discovery to Product was founded in 2014.
How many portfolio companies does Discovery to Product have?
Discovery to Product has 4 portfolio companies in Caplight's dataset.
What are some companies in Discovery to Product's portfolio?
Portfolio companies visible on Caplight include Atrility Medical, Last Lock, BrainXell Therapeutics, BrainXell.
What was Discovery to Product's most recent investment shown here?
Discovery to Product's most recent investment in this portfolio sample was in Atrility Medical in 2024.
What sectors does Discovery to Product focus on?
Discovery to Product focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Real Estate & PropTech, Enterprise Software.
What company stages does Discovery to Product focus on?
Discovery to Product typically invests at the Early stage.